ResearcherLeiden University Medical CenterActive in the last 2 years
Andrea Vallés‐Martí
Matched on ORCID iD 0000-0002-6557-0130; OpenAlex author ID A5027918374. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 4
- The closer, the better: intratumoral delivery of a thermoresponsive gemcitabine-loaded hydrogel in preclinical PDAC models. Co-author DOI 10.1007/s13346-026-02187-6↗
- Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues. Co-author DOI 10.1002/1878-0261.13625↗
- Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2023.112581↗
- Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers. First author DOI 10.1007/s13402-020-00548-y↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Elisa Giovannetti · 3 shared papers, 2020–2024 · strength 0.46
- Paper Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues. DOI 10.1002/1878-0261.13625↗
- Paper Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2023.112581↗
- Paper Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers. DOI 10.1007/s13402-020-00548-y↗
- Connie R. Jiménez · 3 shared papers, 2020–2024 · strength 0.46
- Paper Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues. DOI 10.1002/1878-0261.13625↗
- Paper Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2023.112581↗
- Paper Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers. DOI 10.1007/s13402-020-00548-y↗
- Maarten F. Bijlsma · 3 shared papers, 2020–2024 · strength 0.46
- Paper Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues. DOI 10.1002/1878-0261.13625↗
- Paper Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2023.112581↗
- Paper Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers. DOI 10.1007/s13402-020-00548-y↗
- Giulia Mantini · 2 shared papers, 2020–2023 · strength 0.27
- Lukas J.A.C. Hawinkels · 1 shared paper, 2026 · strength 0.26
- Helena M. Kelly · 1 shared paper, 2026 · strength 0.26
- Joanne Verheij · 1 shared paper, 2024 · strength 0.20
- Frederike Dijk · 1 shared paper, 2024 · strength 0.20
- Paul Manoukian · 1 shared paper, 2023 · strength 0.16
- Tessa Y. S. Le Large · 1 shared paper, 2020 · strength 0.11
- Niccola Funel · 1 shared paper, 2020 · strength 0.11
- Mjriam Capula · 1 shared paper, 2020 · strength 0.11
- Geert Kazemier M · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.